Parent for different guidelines
To improve the robustness and transparency of scientific reporting, the American Society for Pharmacology and Experimental Therapeutics (ASPET), with input from PAASP’s Martin Michel, T.J. Murphy and Harvey Motulsky, has updated the Instructions to Authors (ItA) for ASPET’s primary research journals: Drug Metabolism and Disposition, Journal of Pharmacology and Experimental …
Transparency of research processes is required not only for evaluating and reproducing results, but also for research synthesis and meta-analysis from the raw data and for effective replication and extension of that work.To improve transparency, the authors provide a consensus-based transparency checklist for behavioural and social …
A long-awaited revision of the ARRIVE guidelines has finally been published (The ARRIVE guidelines 2019).What impact can we expect from ARRIVE 2.0? At the very least, we hope that the Nature journals will update their life sciences checklist, which will certainly have an impact. As an example, let’s …
Many areas of biomedical science have developed reporting standards and checklists to support the adequate reporting of scientific efforts, but in vitro research still has no generally accepted criteria. In this article, the authors discuss ‘focus points’ of in vitro research, ensuring that the scientific community …
The Handbook of Experimental Pharmacology is one of the most authoritative and influential book series in pharmacology. It provides critical and comprehensive discussions of the most significant areas of pharmacological research.PAASP members have contributed to the new Handbook of Experimental Pharmacology “Good Research Practice in Pharmacology …
GPCAP provides recommendations on good submission and presentation practice for scientific and medical congresses. These recommendations cover conference abstracts, posters and slides for oral presentations. GPCAP focuses on company-sponsored research i.e. research that is sponsored and/or funded by a pharmaceutical, medical device or biotechnology company. Company-sponsored …
For all different stakeholders within the scientific community (researchers, reviewers, editors, policymakers, funding agencies, journalists, and the general public) it is important that scientific claims are as accurate as possible. However, there is increasing evidence questioning the robustness and accuracy of social and biomedical research outcomes. …
There is a growing concern that flawed statistics and deficient reproducibility in biomedical studies results in an unethical waste of animals in research. This review by Romain-Daniel Gosselin aims to provide guidelines in biostatistics for researchers, based on frequently observed mistakes, misuses and misconceptions as well …
